FTC sees 'turning point' in battle against pay-for-delay

The U.S. government's decade-long fight to limit drugmakers' ability to keep generic medicines off the market may reach "a turning point" soon, Federal Trade Commission Chairman Jonathan Leibowitz told Bloomberg. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.